Only thing that bothers me about the results is that the sample size was so small (40 something of each sample). These will obviously have to be redone with much larger size (1000 or more) but at Abbott's (or whoever's) cost.
I remember with the Japanese Recaf results were about 5-10% lower than with the small sample. Still excellent but down to 85% instead of 90-95%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.